Le Bonheur to test promising new drug on babies battling RSV
Le Bonheur is the “main place” for the worldwide test of a antiviral drug known as ALS-008176, which could redefine how RSV cases are handled, said Dr. John DeVincenzo, medical director, molecular and viral diagnostics at Le Bonheur. He’s the lead author of a study — published last week in the New England Journal of… Read More